Port-Wine Stain

Vbeam Pro will be unveiled at the 2025 Annual Meeting of American Society for Laser Medicine and Surgery (ASLMS) MARLBOROUGH, Mass., April 24, 2025 /PRNewswire/ -- Candela Corporation, a global leader in energy-based medical aesthetics, proudly announced the launch of the Vbeam Pro platform at the 2025 Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS), held in Orlando, FL. Representing the most significant advancement in Candela's four-decades of clinical leadership in pulsed dye laser (PDL) technology, the Vbeam Pro device sets a new market standard for the treatment of vascular and dermatologic conditions. Continue Reading Vbeam Pro Logo Vbeam Pro Device The Vbeam Pro device is the only vascular laser FDA-cleared for use in pediatric patients and combines an advanced 595 nm pulsed dye laser with a 1064 nm Nd:YAG wavelength to offer unmatched precision, accuracy, and treatment versatility. The platform is designed to effectively treat a broad spectrum of skin conditions, including rosacea, port-wine stains, acne, leg veins, spider veins, scars, benign pigmented lesions, wrinkles, warts, stretch marks, and photoaging. "The Vbeam Pro system is a transformative evolution in pulsed dye laser technology," says Dr. Roy Geronemus, Clinical Professor in the Department of Dermatology at NYU Grossman School of Medicine and Medical Director of the Vascular Birthmarks Foundation. "The clinical results are remarkably consistent, and patients are experiencing enhanced outcomes compared to earlier-generation systems," he adds. With its dual wavelengths and 30% tighter energy delivery control, the Vbeam Pro laser offers a new level of efficacy and efficiency for clinicians treating patients across all Fitzpatrick skin types (I–VI). The platform also features optimized dye life and an enhanced user interface, delivering a superior treatment experience for both practitioners and patients. Backed by rigorous clinical research, the Vbeam Pro laser has demonstrated: 20% improved clearance of treated lesions¹ 50% faster treatment times² 20% reduction in reported patient discomfort³ "Reinforcing Candela's commitment to scientific rigor, the Vbeam Pro system underwent extensive clinical evaluation at leading dermatology practices across the United States," says Konika Patel Schallen, MD, Senior Vice President of Clinical Operations and Medical Director at Candela. "We put the platform through stringent testing, using it in busy clinical environments on a wide variety of skin types and conditions. We are excited about the feedback from our dermatology users on enhancing patient outcomes and treatment efficiency." she concludes. "Building on Candela's longstanding clinical leadership, the introduction of the Vbeam Pro system represents a major leap forward in the treatment of vascular and other skin conditions," said Geoffrey Crouse, Chief Executive Officer of Candela. "This milestone launch reflects our unwavering commitment to continuous innovation, rooted in proven science, consistent clinical outcomes, and trusted partnerships with both healthcare providers and patients." Attendees of ASLMS 2025 are invited to experience the Vbeam Pro device by visiting Candela at Booth #321. For more information, please visit: candelamedical.com 1. Compared to Vbeam Perfecta; Vbeam 595 nm output Accuracy and Precision data on file 2. Supported by early LCR participant treatment feedback 3. Data from LCR sites relative to Perfecta 4. Based on patient reports from LCR sites relative to prior Vbeam systems Media Contact: Lindsey Hans, [email protected] SOURCE CANDELA WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

The gala raised hundreds of thousands of dollars that will go directly toward vital medical care for children with physical and cosmetic deformities SAN DIEGO, Nov. 11, 2024 /PRNewswire/ -- Continuing their incredible mission to transform the lives of underprivileged children through no-cost reconstructive medical care, global nonprofit Fresh Start Surgical Gifts hosted its 33rd Annual Butterfly Ball in San Diego, California, sponsored by Axos Bank and Salvatore J. Pacella Plastic Surgery. With hundreds in attendance, this year's Butterfly Ball celebrated the extraordinary, life-changing work of the nonprofit and the generous support of its donors, while also raising funds to provide reconstructive surgeries for disadvantaged children around the world. Continue Reading All money raised by the nonprofit goes directly toward medical care, ensuring no patient will be left uncared for. Post this Fresh Start Surgical Gifts hosted their 33rd Annual Butterfly Ball. The 33rd Annual Butterfly Ball raised hundreds of thousands of dollars, which will go directly toward helping dozens of children receive the life-altering medical care they desperately need. Children from across the United States and around the world seek Fresh Start's medical services and attend the nonprofit's Surgery Weekends, where experts in reconstructive surgery donate their time and skills to transform the lives of children. Fresh Start's volunteer medical team provides world-class care for children and adolescents with a wide range of medical conditions, such as microtia, hemangioma, neurofibromatosis, hairy nevus, Apert syndrome, cleft lip and palate, Treacher Collins syndrome, port-wine stains and hemifacial microsomia. The nonprofit also treats children and adolescents suffering from deformities caused by abuse, disease and accidents who are unable to afford medical care. The money raised from Fresh Start's Annual Butterfly Ball not only goes toward reconstructive surgeries for these patients but also helps fund speech therapy sessions, minor treatments, postoperative appointments, evaluations for ongoing patients and consultations with new patients. Fresh Start has been providing comprehensive medical care to children around the world since 1991, having transformed the lives of over 9,000 children and teens through more than 23,000 reconstructive surgeries. With care from world-class surgeons and medical staff, Fresh Start's annual gala ensures that no family will ever receive a bill for the medical services their child receives and that each patient undergoes thorough postoperative care so they can grow up to lead healthy, productive lives. Beyond medical transformations, the impact on these children's lives extends even further. Patients experience a profound increase in self-esteem and confidence, with many reporting feeling empowered to pursue their dreams—90% are even inspired to enter medical fields themselves. Additionally, the majority engage more actively in healthy habits, resulting in an overall improvement in their well-being, happiness and quality of life. Over 98% are currently enrolled in school or employed, highlighting how this care contributes to both their immediate and long-term success. Through funds raised from its annual Butterfly Ball and general donations sent in through Fresh Start's website, the nonprofit has been able to make a lasting impact on the lives of hundreds of children from around the world. All money raised by the nonprofit goes directly toward providing comprehensive medical care with a team of world-class volunteer surgeons, ensuring no patient will be left uncared for. For more information on Fresh Start Surgical Gifts or to make a donation, visit FreshStart.org. For media inquiries, please contact [email protected]. For photos from the 33rd Annual Butterfly Ball, click here. Esta información y el comunicado de prensa están disponibles en español para los medios de comunicación que así lo requieran. About Fresh Start Surgical Gifts Since 1991, Fresh Start Surgical Gifts has been transforming the lives of underprivileged infants, children and adolescents from all over the world through the gift of reconstructive surgery. With medical care offered in California, Texas, Illinois, Massachusetts and Costa Rica, Fresh Start Surgical Gifts' team of world-class surgeons and medical professionals volunteer their time to treat children with physical deformities caused by birth, accidents, abuse or disease. Ensuring every patient receives the highest quality treatment, Fresh Start's commitment goes beyond medical care, empowering children to leave feeling more confident and self-assured. All monetary contributions to Fresh Start go directly to funding patient's medical procedures, making sure all care comes at no cost to the patient or their families. To learn more and donate, visit FreshStart.org. Contact: Karla Nafarrate Vice President of Public Relations InnoVision Marketing Group [email protected] SOURCE Fresh Start Surgical Gifts WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

The new Vbeam Prima platform takes Candela’s “gold standard” 595 nm Pulsed Dye Laser (PDL) to the next level PALM DESERT, Calif., April 05, 2019 (GLOBE NEWSWIRE) -- Dr. Ken H. Jesser of Vein Specialists Institute in Palm Desert, California announces the acquisition of the Vbeam® Prima™ laser system by Candela, an advanced 595 nm pulsed dye laser (PDL). With the addition of a 1064 nm wavelength and a number of other new features, the Vbeam Prima device will effectively treat a broad range of skin conditions, including rosacea, port wine stains, acne, facial, leg and spider veins, scars, benign pigmented lesions and wrinkles, warts, stretch marks and photo aging. ­ “In a clinical study1 using the Vbeam Prima laser system, facial redness and rosacea symptoms were significantly reduced from moderate to mild after four treatments,” said Dr. Jesser. “I am extremely excited about the new enhancements, especially the 50% greater power enabling a 15 mm spot size, both contact and spray cooling, once-a-day calibration and extended dye life thanks to a complete re-design,” Dr. Jesser added. The Vbeam device is a highly efficient PDL used by healthcare providers all over the world to treat a variety of indications for both face and body with high patient tolerability and a low incidence of side effects. The Vbeam laser has been long considered the “gold standard” for the device based treatment of rosacea, and has also been successfully used for the treatment of port wine stains and vascular anomalies in infants, as well as adults. It is currently used in nearly 700 universities and hospitals worldwide, and has been included in hundreds of medical publications. The new Vbeam Prima laser system builds on that legacy of success by offering advanced features that will help physicians and their patients achieve better results, along with an improved treatment experience. Dr. Jesser will begin treating clients using the Vbeam Prima laser system in April 2019. To schedule a consultation, please contact Vein Specialists Institute at (760)341-7563 or info@ezveins.com. For more information about Dr. Ken Jesser, please visit www.ezveins.com. For more information about the Vbeam Prima laser system, please visit https://syneron-candela.com/na/prima Dr. Kenneth H. Jesser The staff at Vein Specialists Institute is dedicated to providing safe, effective, and affordable nonsurgical solutions for patients with vein problems. Kenneth Jesser, M.D., a graduate of Johns Hopkins Medical School, has practiced continuously in the desert since 1988. A double board-certified internist and emergency physician, he is also a board-certified vein specialist by the American Board of Phlebology. In addition to vein treatments, we also specialize in skin and body procedures utilizing state-of-the-art lasers, light-based therapies, and radio-frequency lasers to treat: wrinkles, brown spots, sun damage, rosacea, melasma, acne scars, as well as loose skin, cellulite and excess fat on the body. In addition, we offer various cosmetic injectables. Candela® Candela is a leading global medical aesthetic device company with an extensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical aesthetic applications including hair removal, wrinkle reduction, tattoo removal, women's health treatments, facial resurfacing, traumatic and surgical scar treatments, body contouring, improving the skin's appearance through the treatment of benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. Candela has a wide portfolio of trusted, leading products, including Vbeam®, the Gentle Family®, CO2RE®, CO2RE Intima®, Profound®, elōs Plus®, PicoWay®, UltraShape®, VelaShape®, Nordlys®, and other laser-based platforms. Acquired by Apax Partners in July 2017, the Company markets, services and supports its products in 86 countries. It has offices in the United States, Australia, Canada, China, France, Germany, Hong Kong, Israel, Italy, Japan, Korea, Portugal, Spain and the United Kingdom and many international distributors. 1. Bernstein EF, Schomacker K, Paranjape A, Jones CJ. Pulsed dye laser treatment of rosacea using a novel 15 mm diameter treatment beam. Lasers Surg Med. 2018;doi:10.1002/lsm.22819 Media Contact: Loni Buckley-Patient Coordinator/Administrator P: (760) 341-7563 | E: loni@ezveins.com EvolveMKDP: (646) 517 4220 | E: candela@evolvemkd.com